Galapagos | GLPG - Net Income

Stock Price
29.06
Daily Change
-0.10 -0.34%
Monthly
6.45%
Yearly
32.94%
Q1 Forecast
27.75

Galapagos reported EUR-202.11M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
argenx SE USD 344.26M 98.9M Sep/2025
AstraZeneca USD 2.53B 83M Sep/2025
Biogen USD 466.5M 168.3M Sep/2025
Genmab DKK 336M 141M Jun/2025
Gilead Sciences USD 3.05B 1.09B Sep/2025
GlaxoSmithKline GBP 2.01B 570M Sep/2025
GRIFOLS EUR 126.96M 9.9M Sep/2025
Hikma Pharmaceutical USD 119M 14M Jun/2025
Incyte USD 424.17M 19.17M Sep/2025
Merck EUR 902M 250M Sep/2025
Neurocrine Biosciences USD 209.5M 102M Sep/2025
Novartis USD 3.93B 96M Sep/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
UCB EUR 857M 649M Dec/2024
Vertex Pharmaceuticals USD 1.08B 50M Sep/2025